» Articles » PMID: 21331778

Revisiting Mendelian Disorders Through Exome Sequencing

Overview
Journal Hum Genet
Specialty Genetics
Date 2011 Feb 19
PMID 21331778
Citations 92
Authors
Affiliations
Soon will be listed here.
Abstract

Over the past several years, more focus has been placed on dissecting the genetic basis of complex diseases and traits through genome-wide association studies. In contrast, Mendelian disorders have received little attention mainly due to the lack of newer and more powerful methods to study these disorders. Linkage studies have previously been the main tool to elucidate the genetics of Mendelian disorders; however, extremely rare disorders or sporadic cases caused by de novo variants are not amendable to this study design. Exome sequencing has now become technically feasible and more cost-effective due to the recent advances in high-throughput sequence capture methods and next-generation sequencing technologies which have offered new opportunities for Mendelian disorder research. Exome sequencing has been swiftly applied to the discovery of new causal variants and candidate genes for a number of Mendelian disorders such as Kabuki syndrome, Miller syndrome and Fowler syndrome. In addition, de novo variants were also identified for sporadic cases, which would have not been possible without exome sequencing. Although exome sequencing has been proven to be a promising approach to study Mendelian disorders, several shortcomings of this method must be noted, such as the inability to capture regulatory or evolutionary conserved sequences in non-coding regions and the incomplete capturing of all exons.

Citing Articles

Variant ranking pipeline for complex familial disorders.

Ralli S, Vira T, Robles-Espinoza C, Adams D, Brooks-Wilson A Sci Rep. 2024; 14(1):13599.

PMID: 38866901 PMC: 11169219. DOI: 10.1038/s41598-024-64169-3.


Closing the gap: Solving complex medically relevant genes at scale.

Mahmoud M, Harting J, Corbitt H, Chen X, Jhangiani S, Doddapaneni H medRxiv. 2024; .

PMID: 38562723 PMC: 10984040. DOI: 10.1101/2024.03.14.24304179.


Applying whole exome sequencing in a consanguineous population with autism spectrum disorder.

Al-Mamari W, Idris A, Al-Thihli K, Abdulrahim R, Jalees S, Al-Jabri M Int J Dev Disabil. 2023; 69(2):190-200.

PMID: 37025335 PMC: 10071987. DOI: 10.1080/20473869.2021.1937000.


Sertoli cell-only syndrome: advances, challenges, and perspectives in genetics and mechanisms.

Wang X, Liu X, Qu M, Li H Cell Mol Life Sci. 2023; 80(3):67.

PMID: 36814036 PMC: 11072804. DOI: 10.1007/s00018-023-04723-w.


Next-Generation Sequencing Advances the Genetic Diagnosis of Cerebral Cavernous Malformation (CCM).

Benedetti V, Canzoneri R, Perrelli A, Arduino C, Zonta A, Brusco A Antioxidants (Basel). 2022; 11(7).

PMID: 35883785 PMC: 9311989. DOI: 10.3390/antiox11071294.


References
1.
Bolze A, Byun M, McDonald D, Morgan N, Abhyankar A, Premkumar L . Whole-exome-sequencing-based discovery of human FADD deficiency. Am J Hum Genet. 2010; 87(6):873-81. PMC: 2997374. DOI: 10.1016/j.ajhg.2010.10.028. View

2.
Collin R, Safieh C, Littink K, Shalev S, Garzozi H, Rizel L . Mutations in C2ORF71 cause autosomal-recessive retinitis pigmentosa. Am J Hum Genet. 2010; 86(5):783-8. PMC: 2869006. DOI: 10.1016/j.ajhg.2010.03.016. View

3.
Day I . dbSNP in the detail and copy number complexities. Hum Mutat. 2009; 31(1):2-4. DOI: 10.1002/humu.21149. View

4.
Teslovich T, Musunuru K, Smith A, Edmondson A, Stylianou I, Koseki M . Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010; 466(7307):707-13. PMC: 3039276. DOI: 10.1038/nature09270. View

5.
Voight B, Scott L, Steinthorsdottir V, Morris A, Dina C, Welch R . Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010; 42(7):579-89. PMC: 3080658. DOI: 10.1038/ng.609. View